OBJECTIVE: The study was conducted to compare the efficacy of two different dose
regimens of misoprostol administered vaginally in combination with mifepristone for second …

OBJECTIVE: To estimate the clinical benefit of pretreatment with mifepristone followed by
misoprostol compared with misoprostol alone for second-trimester abortion. METHODS: Two …

The objective of this study was to confirm the effectiveness and safety of self-administration
of misoprostol every 24 h, for abortion up to 9 weeks of gestation. A group of 720 volunteer …

BACKGROUND: Medical abortion regimens based on the use of either misoprostol alone or
in association with mifepristone have shown high efficacy and excellent safety profile in …

Objective To investigate the clinical efficacy of the combination of mifepristone and an orally
active prostaglandin, misoprostol, for early medical termination. Design Women with …

Increased access to medical methods of abortion could significantly reduce maternal
mortality, especially in developing countries. In light of the political and commercial …

OBJECTIVE: To compare the efficacy of the vaginal and sublingual administration of the
synthetic prostaglandin misoprostol with the currently used oral administration route in …

Background In 2014, a composite pack containing mifepristone‐buccal misoprostol,
indicated for use to 63 days gestation replaced the existing regimen for early medical …

BACKGROUND Home use of misoprostol for termination of pregnancy is still controversial in
many countries. Acceptability of home use of misoprostol has been investigated in …

PIP: The acceptability of medical abortion (mifepristone and misoprostol) among US women
was investigated in a 1995 survey of 262 women seeking this method of pregnancy …